| Model Number |
SMXP135RH |
| Medical Device Problem Code |
Material Rupture (1546)
|
| Health Effect - Clinical Code |
Deformity/ Disfigurement (2360)
|
| Date of Event |
10/01/2021
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that a (b)(6) year-old caucasian female patient underwent an unspecified breast implantation procedure with an artoura breast tissue expander 500cc and experienced deflation on the right side post-operatively.As a result, the patient underwent removal and replacement with an unspecified saline tissue expander on (b)(6) 2021.
|
| |
|
Additional Manufacturer Narrative
|
|
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Reason for device explant and/or reoperation: deflation.Manufacturer¿s reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
Device evaluation summary: no leak test was necessary to determine the location of the tear as we observed a tear at the union between the shell and the suture tab in the 6 o¿clock position.When evaluated under a microscope, the tear pattern did not reveal parallel striations that are consistent with markings made by a sharp instrument.The results also confirmed that there were no abnormalities with the manufacturing of the tissue expander that would have impacted its performance.Therefore, we were unable to identify the root cause of this tear.Our quality assurance process is robust for every product we make and requires that each mentor product undergoes a stringent visual inspection and rigorous testing prior to shipment.In addition, we maintain a comprehensive quality assurance system that complies with the food and drug administration's (fda) good manufacturing practice regulations.Prior to shipping, our devices are checked to ensure that they satisfy these standards in accordance with these processes.We also closely and continually monitor and review clinical performance and real-world evidence for all of our products through clinical studies, registries and post-market surveillance activities.Potential cause while deflation is historically the most common complication related to tissue expanders, the rate of deflation with mentor® tissue expanders remains very low.An incident of this nature may be the result of one or more of the following factors: over inflation of the tissue expander, use of the tissue expander in emerging surgical techniques not identified in the instructions for use (ifu), continuous and sustained stresses to the tissue expander, vigorous body movement (e.G.Physical exercise) or excessive manipulation/ trauma in the region of the expander.Manufacturer¿s reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
On nov 22 2021, the mentor failure analysis lab received the device for evaluation.The analysis has begun, but is not complete at this time.When the investigational analysis has been completed, a supplemental report will be submitted.Manufacturer¿s reference number: (b)(4) on dec 13 2021, it was noticed the previous report contained an error in section b5.The reported explantation date was on (b)(6) 2021.The correct explantation date is on (b)(6) 2021.
|
| |
|
Search Alerts/Recalls
|